---

Cardinal Health Board Of Directors Declares Fourth Quarter Dividend And Authorizes A $500 Million Increase In Share-repurchase Program

DUBLIN, Ohio, August 7, 2002 - The board of directors of Cardinal Health, Inc. (NYSE: CAH), the leading provider of products and services supporting the health care industry, today declared a regular quarterly dividend and increased the authorization under its share-repurchase program.

The dividend of $0.025 per common share, without par value, is payable on October 15, 2002 to shareholders of record on October 1, 2002. Cardinal Health had approximately 447 million shares outstanding as of July 31, 2002.

The increased share-repurchase authorization permits the company to repurchase up to an additional $500 million of its common shares. The company will hold any repurchased shares as treasury shares and intends to use them for general corporate purposes, including acquisitions and for issuance upon exercise of outstanding stock options. The current share repurchase authorization, announced in September 2001, is expected to be completed in mid-August, 2002. As of August 6, 2002, approximately $468 million was spent to repurchase shares. Under the board's new authorization of an additional $500 million for share-repurchase, the company may begin purchasing pursuant to terms management deems appropriate and at such time as it may designate.

"Investors have come to expect consistent and stable growth from our company and we delivered this superior financial performance again in the fourth quarter and fiscal year 2002," said Robert D. Walter, chairman and chief executive officer of Cardinal Health. "The board's authorization of an increased stock-repurchase program, combined with our record operating cash flow and historically low debt-to-capital position, gives us flexibility to invest in our own stock by repurchasing shares while continuing to invest in future growth."

About Cardinal Health

Cardinal Health, Inc. (www.cardinal.com) is the leading provider of products and services supporting the health care industry. Cardinal Health companies develop, manufacture, package and market products for patient care; develop drug-delivery technologies; distribute pharmaceuticals, medical-surgical and laboratory supplies; and offer consulting and other services that improve quality and efficiency in health care. Headquartered in Dublin, Ohio, Cardinal Health employs more than 49,000 people on five continents and produces annual revenues of more than $44 billion. Cardinal Health is ranked #23 on the current Fortune 500 list and was named one of the "The World's Best" companies by Forbes magazine in 2002.

---

Except for historical information, all other information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. The most significant of these uncertainties are described in Cardinal Health's Form 10-K, Form 8-K and Form 10-Q reports and exhibits to those reports, and include (but are not limited to) the costs, difficulties, and uncertainties related to the integration of acquired businesses, the loss of one or more key customer or supplier relationships, changes in the distribution outsourcing patterns for health-care products and/or services, the costs and other effects of governmental regulation and legal and administrative proceedings, and general economic conditions. Cardinal undertakes no obligation to update or revise any forward-looking statements.